Colgate-Palmolive Company (N:CL)

Sector:  Consumer Non-Cyclicals Industry:  Personal Products
 
See Regulatory Filings on SEC
Company Contact
Address: 300 PARK AVE
NEW YORK NY 10022-7402
Tel: N/A
Website: https://www.colgatepalmolive.com
IR: See website
<
Key People
Noel R. Wallace
Chairman of the Board, President, Chief Executive Officer
Stanley J. Sutula
Chief Financial Officer
Prabha Parameswaran
Group President - Growth and Strategy
Panagiotis Tsourapas
Group President, Europe and Developing Markets
Sally Massey
Chief Human Resource Officer
Gregory Malcolm
Executive Vice President, Controller
John W. Kooyman
Chief of Staff
Jennifer M. Daniels
Chief Legal Officer and Secretary
 
Business Overview
Colgate-Palmolive Company manufactures a range of products for the personal and home care markets. It operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. The Company sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Through Hill's Pet Nutrition, it is also engaged in the pet nutrition market, selling products principally through authorized pet supply retailers, veterinarians and e-commerce retailers.
Financial Overview
For the three months ended 31 March 2024, Colgate-Palmolive Company revenues increased 6% to $5.07B. Net income increased 84% to $683M. Revenues reflect Oral, Personal and Home Care segment increase of 7% to $3.96B, Pet Nutrition segment increase of 4% to $1.1B, Latin America segment increase of 17% to $1.25B, Europe segment increase of 9% to $711M, North America segment increase of 4% to $997M. Net income benefited from Oral.
Employees: 34,000 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $83,582M as of Mar 31, 2024
Annual revenue (TTM): $19,752M as of Mar 31, 2024
EBITDA (TTM): $4,769M as of Mar 31, 2024
Net annual income (TTM): $2,611M as of Mar 31, 2024
Free cash flow (TTM): $1,270M as of Mar 31, 2024
Net Debt Last Fiscal Year: $7,379M as of Mar 31, 2024
Shares outstanding: 820,441,114 as of Mar 31, 2024
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.